The effect of non-AIDS-defining cancers on people living with HIV
Non-AIDS-defining cancers are a growing source of morbidity for people with HIV globally.
Although people living with HIV have a disproportionately increased risk of developing …
Although people living with HIV have a disproportionately increased risk of developing …
Navigating the Nexus: HIV and Breast Cancer—A Critical Review
A Marino, G Pavone, F Martorana, V Fisicaro… - International Journal of …, 2024 - mdpi.com
Despite significant advances in the management of antiretroviral therapy (ART), leading to
improved life expectancy for people living with HIV (PLWH), the incidence of non-AIDS …
improved life expectancy for people living with HIV (PLWH), the incidence of non-AIDS …
Disparities in breast cancer survival between women with and without HIV across sub-Saharan Africa (ABC-DO): a prospective, cohort study
Background Studies have shown increased mortality among women living with HIV
diagnosed with breast cancer compared with HIV-negative women with breast cancer. We …
diagnosed with breast cancer compared with HIV-negative women with breast cancer. We …
Impact of HIV infection on survival among women with stage I‐III breast cancer: results from the South African breast cancer and HIV outcomes study
OA Ayeni, DS O'Neil, YS Pumpalova… - … journal of cancer, 2022 - Wiley Online Library
In some countries of sub‐Saharan Africa, the prevalence of HIV exceeds 20%; in South
Africa, 20.4% of people are living with HIV. We examined the impact of HIV infection on the …
Africa, 20.4% of people are living with HIV. We examined the impact of HIV infection on the …
How immunodeficiency can lead to malignancy
Immunodeficiency, whether acquired in the case of human immunodeficiency virus (HIV)
infection or congenital due to inborn errors of immunity (IEIs), presents clinically with not only …
infection or congenital due to inborn errors of immunity (IEIs), presents clinically with not only …
Relative dose intensity and pathologic response rates in patients with breast cancer and with and without HIV who received neoadjuvant chemotherapy
YM Martei, M Narasimhamurthy, DI Setlhako… - JCO Global …, 2022 - ascopubs.org
PURPOSE Patients who are HIV-positive and have breast cancer have worse overall
survival (OS) compared with patients who are HIV-negative. Pathologic complete response …
survival (OS) compared with patients who are HIV-negative. Pathologic complete response …
[HTML][HTML] Survival disparities between patients with breast cancer with and without HIV: a research framework
S Chasimpha, I dos Santos Silva, YM Martei… - JCO Global …, 2023 - ncbi.nlm.nih.gov
Because of potent antiretroviral therapy (ART), most women infected with HIV now live
longer to ages when breast cancer incidence rates are high. 1 Although not at increased risk …
longer to ages when breast cancer incidence rates are high. 1 Although not at increased risk …
A review of the nucleic acid-based lateral flow assay for detection of breast cancer from circulating biomarkers at a point-of-care in low income countries
The current levels of breast cancer in African women have contributed to the high mortality
rates among them. In South Africa, the incidence of breast cancer is also on the rise due to …
rates among them. In South Africa, the incidence of breast cancer is also on the rise due to …
The association of HIV status with triple-negative breast cancer in patients with breast cancer in South Africa: a cross-sectional analysis of case-only data from a …
Background Breast cancer is the most common malignancy diagnosed among women in
South Africa, with the aggressive triple-negative subtype comprising approximately 15% of …
South Africa, with the aggressive triple-negative subtype comprising approximately 15% of …
Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus
CE Henson, DJ Morton, JS Mayadev, SJ Wong… - Cancer, 2023 - Wiley Online Library
Despite strong recommendations for their inclusion in cancer clinical trials, people living with
human immunodeficiency virus continue to be underrepresented or have inadequate data …
human immunodeficiency virus continue to be underrepresented or have inadequate data …